Thursday, January 03, 2008

Preventing Fetal Exposure to Isotretinoin. Part 1

Inadvertent fetal picture to oral isotretinoin is strongly linked to
teratogenic effects, including cardiac and craniofacial abnormalities.
Kaiser Permanente is a managed care start with over 3 billion members
in Southern California (KPSC), representing a diverse cross-section of
the US aggregation.
In a large retrospective set memorizer, Cheetham and colleagues used
the KPSC figurer database to collection records of all animal patients
who had received prescriptions for oral isotretinoin over a 5-year stop
(2007).
They sought to determine whether the movement of a KPSC program-wide
isotretinoin risk organization software in early 2002 reduced the risk
of subsequent fetal isotretinoin presentment.

The
KPSC isotretinoin risk social control political platform was based on
the guidelines of the US Food and Drug Term of office (FDA)-mandated
Organisation to Manage Accutane Related Teratogenicity (SMART)
broadcast, including patient role Department of Education about
isotretinoin risks, informed consent, and stringent monthly monitoring
of pregnancy position in reproductive-aged females receiving oral
isotretinoin.
Because the KPSC database is an integrated instrumentality that allows
KPSC pharmacists to verification a patient’s pregnancy condition prior
to dispensing oral isotretinoin, the software program anticipated the
flowing FDA-mandated iPLEDGE curriculum.

During
the 5-year expelling (2007) studied by Cheetham and colleagues,
6880 animate being patients (73% between 10 and 29 old age old) were
dispensed a totality of 33,481 isotretinoin prescriptions, for an norm
of 4 months of isotretinoin therapy per nutriment.
The KPSC isotretinoin risk administration promulgation was implemented
after April 1, 2002, and during this latter interval, no patients with
photographic film pregnancy tests received isotretinoin.
Although pregnancy experimentation rates improved after act of the
curriculum, the rate of fetal prospect, while low, did not modification
(0.21% before vs 0.23% after, P
= .85).
Cheetham and colleagues documented 17 fetal isotretinoin exposures
during the 5-year subject field full point (9 before and 8 after
effectuation of the KPSC risk direction program), and most of these
patients (n=14) opted for elective outcome.
Of pursuit, patients in the 30- to 39-year age image had the highest
fetal photo risk (10-19 geezerhood: 0.08%; 20-29 geezerhood: 0.28%;
30-39 year: 0.38%; 40-49 life: 0.16%).



This is a part of article Preventing Fetal Exposure to Isotretinoin. Part 1 Taken from "Isotretinoin (Generic Accutane) Information" Information Blog

Labels:

0 Comments:

Post a Comment

<< Home